64 research outputs found
Effect of opium on glucose metabolism and lipid profiles in rats with streptozotocin-induced diabetes
Wstęp: To eksperymentalne badanie przeprowadzono w celu określenia wpływu stosowania opium na profil lipidowy i metabolizm
glukozy u szczurów z cukrzycą wywołaną podaniem streptozotocyny.
Materiał i metody: Aby ocenić wpływ opium, 20 samców podzielono na dwie grupy: kontrolną (n = 10) i otrzymującą opium (n = 10). Po
wywołaniu cukrzycy przez 35 dni codziennie mierzono stężenie glukozy we krwi zwierząt. Profil lipidowy i odsetek hemoglobiny A1c
(HbA1c) określono na poczatku badania (przed wywołaniem cukrzycy) i w 35. dniu obserwacji.
Wyniki: Poziom glikemii u szczurów, którym podawano opium i w grupie kontrolnej był podobny (544,8 ± 62,2 mg/dl v. 524,6 ± 50,0 mg/dl,
P = 0,434). Ponadto, nie stwierdzono różnic między grupą leczoną i kontrolną w zakresie wartości HbA1c (6,5 ± 0,5% v. 6,6 ± 0,2%, P = 0,714).
Również stężenia cholesterolu całkowitego, cholesterolu frakcji HDL, triglicerydów i lipoproteiny (a) były podobne w obu grupach.
Wnioski: Stosowanie opium nie ma istotnego wpływu na metabolizm glukozy i profil lipidowy u szczurów z eksperymentalnie wywołaną
cukrzycą.Background: This experimental study was performed to determine the impact of opium use on serum lipid profile and glucose metabolism
in rats with streptozotocin-induced diabetes.
Material and methods: To determine the effect of opium, 20 male rats were divided into control (n = 10) and opium-treated (n = 10)
groups. After diabetes induction, the animals were investigated for daily glucose measurements for 35 days. Serum lipid profile and
haemoglobin A1c (HbA1c) were assayed at the baseline (before induction of diabetes) and at 35-day follow-up.
Results: The glycaemia levels in the rats treated with opium were similar to the levels measured in the control rats (544.8 ± 62.2 mg/dl v.
524.6 ± 50.0 mg/dl, P = 0.434). In addition, there was no difference between the opium-treated rats and control rats in HbA1c (6.5 ± 0.5% v.
6.6 ± 0.2%, P = 0.714). Compared to the control rats, the serum total cholesterol, high density lipoprotein (HDL), triglyceride and lipoprotein
(a) in the test animals were similar.
Conclusion: Opium use has no significant effect on glucose metabolism and serum lipid profile in rats with induced diabetes
Dystrophic Epidermolysis Bullosa: COL7A1 Mutation Landscape in a Multi-Ethnic Cohort of 152 Extended Families with High Degree of Customary Consanguineous Marriages
Dystrophic epidermolysis bullosa is a heritable skin disease manifesting with sub-lamina densa blistering, erosions, and chronic ulcers. COL7A1, encoding type VII collagen, has been identified as the candidate gene for dystrophic epidermolysis bullosa. In this study, we have identified COL7A1 mutations in a large multi-ethnic cohort of 152 extended Iranian families with high degree of consanguinity. The patients were diagnosed by clinical manifestations, histopathology, and immunoepitope mapping. Mutation detection consisted of a combination of single nucleotide polymorphism-based whole-genome homozygosity mapping, Sanger sequencing, and gene-targeted next-generation sequencing. A total of 104 distinct mutations in COL7A1 were identified in 149 of 152 families (98%), 56 (53%) of them being previously unreported. Ninety percent of these mutations were homozygous recessive, reflecting consanguinity in these families. Three recurrent mutations were identified in five or more families, and haplotype analysis suggested a founder effect in two of them. In conclusion, COL7A1 harbored mutations in the overwhelming majority of patients with dystrophic epi-dermolysis bullosa, and most of them in this Iranian cohort were consistent with autosomal recessive inheri-tance. The mutation profile attests to the impact of consanguinity in these families
Gene-Targeted Next Generation Sequencing Identifies PNPLA1 Mutations in Patients with a Phenotypic Spectrum of Autosomal Recessive Congenital Ichthyosis: The Impact of Consanguinity
Heritable forms of ichthyoses, also referred to as generalized
Mendelian disorders of cornification, are phenotypically a
highly heterogeneous group of conditions caused by mutations
in a number of genes playing a role in keratinocyte differentiation and epidermal barrier function (Baden and Digiovanna,
2013; Schmuth et al., 2013). These diseases are characterized
by scaling and hyperkeratosis with associated cutaneous and
extracutaneous features. This group of disorders is also genetically heterogeneous, with autosomal dominant, autosomal
recessive, and X-linked inheritance being described. A specific
subgroup of inherited ichthyoses is the autosomal recessive
congenital ichthyosis (ARCI), with many newborns presenting
as collodion babies, but the subsequent clinical presentation
and the spectrum of severity can be highly variable (Richard and
Bale, 2014). In the most severe forms, such as harlequin ichthyosis, the disease is often fatal during the early postnatal
period, whereas at the other end of the continuum of the
spectrum, the disease may present with a relatively mild scaling
and variable degree of palmoplantar keratoderma. There is
considerable genetic heterogeneity in ARCI, and as many as
nine different genes are known to harbor biallelic mutations;
these include TGM1, ALOXE3, ALOX12B, NIPAL4, ABCA12,
CYP4F22, PNPLA1, LIPN, and CERS3. Previous reports have
suggested that mutations in TGM1 account for 30e65% of patients with ARCI, whereas mutations in LIPN, PNPLA1, and
CERS3 have been reported only in a few consanguineous
families (Richard and Bale, 2014).
With the advent of next generation sequencing (NGS),
there has been tremendous progress in facilitating the mutation detection in various heritable skin disorders, including
ichthyosis (South et al., 2015; Takeichi et al., 2013). In fact, at
least 38 different genes have now been suggested to be
associated with the ichthyotic phenotypes, either as the primary mutated genes or modifying the phenotypic presentation. To elucidate the genetic basis of ichthyosis in Iran, a
country of approximately 80 million people with high prevalence of customary consanguineous marriages, we developed a gene-targeted NGS array consisting of 38 genes
reported in association with ichthyosis phenotypes. Identification of specific mutations in a large number of families has
allowed us to examine phenotype/genotype correlations with
respect to both intra- and interfamilial heterogeneity, in part
because of extensive consanguinity in these families. In this
study, we identified six distinct and, to our knowledge, previously unreported mutations in the PNPLA1 gene in nine
families
Is There A Relationship Between The Components Of Metabolic Syndrome And Depression?
Introduction: Metabolic syndrome is characterized as, have at least 3 of the following 5 criteria: high waist circumference, high blood pressure, high Triglyceride, low HDL (High Density Lipoprotein), and elevated Fasting Blood Glucose. The International Diabetes Federation estimates that 25% of the world's population has metabolic syndrome. Specially, metabolic syndrome is more prevalence in depressed people and other psychiatric patients, but some studies do not confirm it. So, we decided to evaluate the association between metabolic syndrome criteria and depression as a most common psychiatric disorder. Method: Our study was a cross sectional design of 130 participants aged 18-65 years. We assessed the metabolic syndrome based on International Diabetes Federation criterion and depression by using the criterion of DSM-IV. Results: After an adjustment for important confounders (Physical activity, calorie intake, history of depression, the depression score, menopausal status, body mass index and dietary patterns) depressed patients significantly had more waist circumference. Conclusion: Maybe visceral obesity results in depression or vice versa. So, we suppose more studies to clarify this relationship
Resistance to demineralisation of adjacent enamel and dentine, fluoride release and dentine bond strength of fluoride-containing self-etch adhesive systems
Background: The current study aimed to assess the amount of fluoride released from fluoride-containing dental adhesives and its effect on micro-tensile bond strength (?TBS) and on resistance to demineralisation of dentine and enamel.Material and Methods: Two fluoride-containing dental adhesives, and a fluoride-free adhesive were used as expe-rimental adhesives. After thermal cycling the ?-TBS of adhesives to dentine and the failure mode were assessed. The fluoride release and cross-sectional microhardness (CSMH) of specimens were measured before and after one day, 7 and 28 days of pH-cycling. The data were analysed using one-way ANOVA, Weibull statistics and repeated measures ANOVA. Results: The results indicated a significant difference between the group of FL and both the SE and LBF groups (p?0.001). The CSMH values of both the dentine and enamel underneath the adhesives was reduced at 28 th day of the pH-cycling compared to the baseline (p?0.001). From day 1 to day 28, the released fluoride declined in both the fluoride containing dental adhesives (p?0.001).Conclusions: Based on the results, the released fluoride from dental adhesives may adversely influence the bond strength and durability of the resin/dentine interface. Moreover, the released fluoride didn?t improve the resistance to demineralisation of adjacent enamel and dentine to bond interface
Association between R353Q polymorphism for coagulative factor VII and severity of coronary artery disease in Iranian population
Background: Recent research has supported the central role of coagulative factors in advancing atherosclerosis and causing coronary artery disease (CAD). The present study, for the first time, aimed to clarify the relationship between R353Q polymorphism for factor VII and the occurrence and severity of CAD in a large sample of Iranian population.Methods: Nine hundred and nineteen consecutive patients with suspected CAD, who candidated for coronary angiography in the Tehran Heart Center between January 2006 and March 2007, were examined. The number of diseased coronary vessels was determined, and the severity of CAD was assessed by the Gensini score. Genotyping was done via the PCR-RFLP method.Results: The frequency of Q and R alleles was 74.1% and 25.9% in the patients with CADand 75.2% and 24.8% in those without CAD, with an insignificant difference (p = 0.625). The frequency of Q allele in the patients with single-vessel, two-vessel, and three-vessel diseases was 72.8%, 71.5%, and 76.4%, respectively; the difference was also insignificant (p = 0.379). No relationship was observed between the distribution of the genotypes and the number of the involved coronary vessels. The average of the Gensini score was 43.39 ± 46.18 in the patients with QQ genotype, 38.87 ± 42.89 in those with QR genotype, and 55.61 ± 53.80 in the ones with RR genotype, with the difference not constituting any statistical significance (p = 0.084).Conclusions: The results suggest no association between R353Q polymorphism for factor VII and the presence or progression of CAD in the Iranian population
Serum Uric Acid Level and Metabolic Syndrome in Patients Undergoing Coronary Angiography
ABSTRACT Background and Objectives: The association between metabolic syndrome (MetS) and hyperuricemia has been formerly studied mostly in healthy people in western countries. We tried to examine the relationship between hyperuricemia and MetS in an Iranian population undergoing coronary angiography. Materials and Methods: From March 2008 to September 2008, we studied 465 patients (260 men, 55.9%) undergoing elective coronary angiography due to symptoms related to coronary artery disease. The MetS was defined according to the adapted Adult Treatment Panel III (ATP-III A), and hyperuricemia was defined as serum uric acid concentrations ≥ 7.0 mg/dl in men and ≥ 6.0 mg/dl in women. For the statistical analysis, the statistical software SPSS version 13.0 and the statistical package SAS version 9.1 were applied Results: The mean age of the study population was 59.66 ± 10.04, ranging from 31 to 85 years. Hyperuricemia was detected in 231 (49.7%) of total population, in 126 (54.5%) of men, and in 105 (45.5%) of women. In the multivariable adjusted model, subjects with MetS and subjects with 5 components of the MetS compared to those without any components of the MetS, had 1.56-fold and 4.19-fold increased odds of hyperuricemia, respectively. Hyperuricemia was significantly associated with elevated BP and low level of HDL-cholesterol but not with other components of MetS. Conclusions: Our study demonstrated that hyperuricemia was strongly associated with the prevalence of MetS according to adapted ATP III guidelines in an Iranian sample of patients undergoing coronary angiography
Association Between Single Nucleotide Polymorphisms of the Interleukin-4 Gene and Atopic Dermatitis
ABSTRACT Atopic dermatitis (AD) is an inflammatory skin disease in which both genetic and environmental factors seem to be involved. Several studies investigated the association of certain genetic factors with AD in different ethnic groups, but conflicting data were obtained. This study was performed to check the possible association between single nucleotide polymorphisms (SNPs) of interleukin 4 (IL-4) and the IL-4 receptor α chain (IL-4Rα) and AD in a group of Iranian patients. The allele and genotype frequencies of genes encoding for IL-4 and IL-4Rα were investigated in 89 patients with AD in comparison with 139 healthy controls, using methods based on polymerase chain reaction sequence-specific primers. The most frequent alleles of IL-4 in patients were T at -1098 (P<0.001, odds ratio (OR)=2.35), C at -590 (P<0.001, OR=4.84) and C at -33 (P=0.002, OR=2.08). The most frequent genotypes of IL-4 in patients were TT, CC, and CC at positions -1098 (P<0.001, OR=3.59), -590 (P<0.001, OR=31.25) and -33 (P<0.001, OR=3.46), respectively. We found a significant lower frequency of GT at -1098 GT, TC at -590, and TC at -33 in patients. There were no statistically significant differences in the frequency of alleles and genotypes of IL-4Rα gene at position +1902. A strong positive association was seen between TCC haplotype and AD (68% in patients vs. 23.4% in controls, P<0.001, OR=8.91). We detected a significantly lower frequency of TTC, GCC, and TTT haplotypes (P<0.001, OR=0.02, P<0.001, OR=0.40, P<0.001, OR=0.39, respectively) in patients compared to controls. A significant association between the polymorphisms of the IL-4 gene promoter at positions -1098, -590, and -33 and AD was detected in the Iranian population. Key words: atopic dermatitis; polymorphism, single nucleotide; interleukin-4 gene</p
Comparing the effect of cardiac biomarkers on the outcome of normotensive patients with acute pulmonary embolism
Acute pulmonary embolism (PE) is a cardiovascular challenge with potentially fatal consequences. This study was designed to observe the association of novel cardiac biomarkers with outcome in this setting. In this prospective study, from 86 patients with a confirmed diagnosis of PE, 59 patients met the inclusion criteria (22 men, 37 women; mean age, 63.36±15.04 y).The plasma concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP), growth differentiation factor-15 (GDF-15), heart-type fatty acid-binding protein (H-FABP), tenascin-C, and D-dimer were measured at the time of confirmed diagnosis. The endpoints of the study were defined as the short-term adverse outcome and long-term all-cause mortality. Totally, 11.8% (7/59) of the patients had the short-term adverse outcome. The mean value of logNT-proBNP was 6.40±1.66 pg/ml. Among all the examined biomarkers, only the mean value of logNT-proBNP was significantly higher in the patients with the short-term adverse outcome (7.88±0.67 vs. 6.22± 1.66 pg/ml; OR, 2.359; 95% CI, 1.037 to 5.367; P=0.041). After adjustment, a threefold increase in the short-term adverse outcome was identified (OR, 3.239; 95% CI, 0.877 to 11.967; P=0.078).Overall, 18.64% (11/59) of the patients had expired by the long-term follow-up. Moreover, adjustment revealed an evidence regarding association between increased logNT-proBNP levels and long-term mortality (HR, 2.163; 95%CI, 0.910 to 5.142; P=0.081). Our study could find evidences on association between increased level of NT-proBNP and short-term adverse outcome and/or long-term mortality in PE. This biomarker may be capable of improving prediction of outcome and clinical care in non-high-risk PE
- …